India's pharma, traditional-medicine sectors face slowdown

05/8/2013 | PharmaBiz.com (India)

The global economic downturn coupled with government austerity measures have slowed the growth of the Indian pharmaceutical industry as well as the Ayurvedic sector. New regulations imposed by the EU to combat the influx of counterfeit medicines have also slowed exports. The best prospects for growth in Indian pharmaceuticals include developing generics and biosimilars, strengthening drug-manufacturing capability, restructuring businesses to allow mergers and acquisitions, and keeping a sharp focus on global markets, say Indian drug-company officials.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX